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The Effects of ArginMax, A Natural
Dietary Supplement for Enhancement of
Male Sexual Function
Thomas Ito MIY; Kaye Kawahara MD, Anurag Das MD, FACS***, Warren Strudwick MD****
This study examines the role of ArginMax, a natural daily dietary
supplement, on male sexual function. 25 subjects diagnosed with
mild to moderate erectile dysfunction were evaluated over a 4-week
period while on ArginMax. Of the 21 subjects that completed the
study, 88.9% improved in ability to maintain erection during sexual
intercourse and 75.0% improved in satisfaction with their overall sex
life. No significant side effects were noted.
Introduction
It has been reported in the literature that dietary supplementation
with certain botanical extracts, vitamins, or amino acids have led to
modest improvements in male sexual function. No studies, how
ever, have examined a systematically designed combination of
natural products for the enhancement ofmale sexual function. Based
on the proposed and elicited mechanisms of various natural products
in the literature, we postulated that a combination regimen
(ArginMax) could provide a major impact in support of male sexual
function. First, a review of the supporting literature.
It is well established that nitric oxide (NO) is the key mediator for
the up-regulation ofcGMP which in turn mediates erectile function.’
L-arginine is the precursor of nitric oxide. The conversion of L
arginine to nitric oxide is mediated by nitric oxide synthase (NOS).
Increasing tissue L-arginine levels results in the increase of NO and
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cGMP.23 Supplementation with L-arginine has been shown to be
sufficient to restore endothelial-derived nitric oxide production in
many disorders in which endothelial-derived nitric oxide is reduced
or impaired including impairment resulting from diabetes and
hypercholesterolemia.48Studies also point to the role of L-arginine
as not only a substrate for NOS in the up-regulation of cGMP, but
also acts to reduce cell-mediated breakdown of nitric oxide.9
The efficacy of Korean ginseng (Panax Ginseng) in treating
erectile dysfunction was recently demonstrated in a randomized
controlled clinical trial involving a total of 90 patients studied over
3 months, 30 each receiving placebo, trazadone, or ginseng.’0
Ginseng was the most efficacious treatment with improvements
measured in erectile parameters such as girth, libido, and patient
satisfaction. Frequency of intercourse, ejaculations, and erections
did not differ among groups. In a controlled study with 66 patients,
Panax ginseng was demonstrated to increase spermatozoa count and
motility, testosterone, DHT, FSH, and LH levels in 66 patients with
fertility problems.” Ginsenosides (the primary active component of
ginseng) have been shown to increase NO production in endothelial
cells.’2.’4One observed mechanism for increase in NO production is
up-regulation of NOS activity by ginsenosides.’4The effects of
ginsenosides on NO production has implications for improved
sexual function, and may partly account for the aphrodisiac effect of
Panax ginseng used in traditional Chinese medicine.
Ginkgo biloba is well established to facilitate microvascular
circulation’5which may physiologically lead to improvement of
erections. In addition to ginkgo biloba’s ability to facilitate mi
crovascular circulation, potentially benefiting erectile function
through enhanced vascular blood flow, there is evidence that ginkgo
biloba extract may also directly elucidate smooth muscle relaxation
in the corpus cavernosum, likely via effects on the nitric oxide
pathway.6?
B-complex vitamins are important to the activity of hundreds of
enzymes and in energy metabolism. Low levels of circulating folate
and vitamin B6 confer an increased risk of peripheral vascular
disease,’8leading to potential reduction of erectile function.
Zinc is a fundamental mineral in the maintenance of human
reproductive function. Low levels of serum zinc has been shown to
cause sexual dysfunction and is associated with infertility in
Zinc deficiency during growth periods results in lack of gonadal
development in males.2’2 Zinc deficiency leads to depletion of
testosterone and inhibition ofspermatogenesis.23Zinc is also thought
to help extend the functional life span of ejaculated spermatozoa.23
Selenium has a key influence on spermatozoa numbers and
motility. It is an essential element in normal spermatozoa develop-
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ment. Selenium is incorporated in the sperm mitochondria capsule
and may thus affect the behavior and function of the spermazoon.24
It has been shown that dietary supplementation with selenium-
vitamin E statistically significantly increases sperm motility, per
cent live, and percent normal spermatozoa.25
It is well established that one of the key roles of seminal plasma
is the protection of spermatozoa against reactive oxygen species.26
In a study of 101 patients seeking consultation for infertility and 15
fertile donors, a strong inverse relationship was found between total
reactive antioxidant potential in seminal plasma and infertility.26
ArginMax (The Daily Wellness Company, Mt. View, CA) is a
natural dietary supplement which incorporates a highly standard
ized combination of ginkgo biloba (24% flavone glycosides, 6%
terpene lactones), Korean ginseng (Panax Ginseng-30%
ginsenosides), American ginseng (Panax Quinquefolius- 5%
ginsenosides), L-arginine, along with B-vitamins 6 and 12, folate,
antioxidant vitamins A, C, F, thiamin, riboflavin, niacin, biotin,
pantothenic acid, zinc, and selenium. ArginMax was developed as
a dietary supplement to support male sexual fitness. This paper
reports our findings of a clinical pilot study of male sexual function
using ArginMax as a daily dietary supplement in a group ofmen with
mild to moderate erectile dysfunction.
Method
We recruited male subjects with mild to moderate erectile dys
function through various medical clinics. Interested participants
were enrolled at a test center located in a urology clinic at a
University of Hawaii affiliated teaching hospital (Kuakini Medical
Center). Subjects were enrolled in a consecutive manner until 25
patients had been enrolled for this pilot phase of the study. All
interested participants were allowed to enroll regardless of etiology
oferectile dysfunction. Initial work up consisted ofa detailed patient
past medical history including history and etiology of erectile
dysfunction, treatment and medication history, and a physical ex
amination including blood pressure, height, and weight. The sub
jects were then instructed on the use and a regimen of ArginMax as
a dietary supplement and were requested to fill out a baseline SFQ
(Sexual Function Questionnaire). Subjects started a twice-per-day
regimen of ArginMax, once in the morning upon waking and once
in the evening at bedtime. A 4-week supply of ArginMax was
provided. After completing the 4-week regimen, patients were
instructed to complete a 4-week SFQ and return to the test center for
follow-up evaluation and examination.
The SFQ (Sexual Function Questionnaire) was used as the pri
mary test instrument. The SFQ is a self-administered questionnaire
beginning with the validated IIEF (International Index of Erectile
Function used with permission) test instrument designed to measure
changes in erectile function and sexual function.27-9Following the
11FF questions, the SFQ included questions regarding subject’s
activities, condition during the trial period, and quality of life.303’
Study Results
Sexual Function Improvements as Measured By SFQ
Patient responses to SFQ variables at 4 weeks were compared to
SFQ responses at baseline. A comparison analysis was performed
for those subjects whose degree of erectile dysfunction were mild to
moderate as characterized by a minimal baseline score of 2 in
comparison to their 4 week score on the same SFQ variable. The
results were then pooled, summarized, and evaluated to reflect the
percentage of subjects with improvement in each of the SFQ
variables. The following are our findings showing the two highest
and two lowest SFQ variable results:
88.9% of subjects showed improvement in the ability to main
tain erection during intercourse, as measured by the following
SFQ variable:
0 = Did not attempt intercourse
_________
1 = Almost never/never
2 = A few times (much less than
half the time)
3 = Sometimes
(about half the time)
4 = Most times (much more that
half the time)
5 = Almost always/always
75.0% of subjects showed improvement in satisfaction with
overall sex life, as measured by the following SFQ variable:
_______
= Very dissatisfied
2 = Moderately dissatisfied
3 About equally satisfied and
dissatisfied
4 Moderately satisfied
5= Very satisfied
20.0% of subjects showed improvement in number of orgasms,
as measured by the following SFQ variable:
0 = No sexual stimulation/intercourse
1 = Almost never/never
2 = A few times
(much less than half the time)
3 = Sometimes (about half the time)
4 = Most times (much more than half
the time)
5 = Almost always/always
12.5% of subjects showed improvement in the number of times
attempted intercourse, as measured by the following SFQ vari
able:
Subject Group Profile At Baseline
Total number of subjects- 25
Age range- 40 - 77
Number hypertensive- 19
Number diabetes mellitus- 4
Over the past 4 weeks, how many times have you
attempted sexual intercourse?
o = No attempts
1 = One to two attempts
2 = Three to four attempts
3 = Five to six attempts
4 = Seven to ten attempts
5= Eleven + attempts
Over the past 4 weeks, during sexual intercourse,
how often were you able to maintain your erection
after you had penetrated (entered) your partner?
Over the past 4 weeks, how satisfied
have you been with your overall sex life?
Over the past 4 weeks, when you had
sexual stimulation t intercourse.
how often did you ejaculate?
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Subjects Dropped
Of the 25 subjects enrolled, 21 were included in the scoring of the
above shown results. Four (4) of the enrolled subjects were not
included for the following reasons:
Loss of sex partner resulting in major change in sexual activity.
(1 subject)
Did not complete study due to personal problems- unspecified.
(1 subject)
Did not complete 4 week regimen in entirety. (2 subjects)
Side Effects
Blood Pressure Changes: no significant change in blood pressure.
Mean blood pressure at baseline:135/82 (s.devs: 14.9/11.71).
Mean blood pressure at 4-weeks: 139/85 (s.devs: 12.26/13.17).
No other significant side effects as noted. The following are net %
of patients reporting increase or decrease of:
headaches: 4.8%
nausea: -4.8%
stomach upset: -14.3%
chest pain: 0%
dizziness: 0%
vision disturbance: 0%
Discussion
The role of natural dietary supplements for
sexual health is an infrequently discussed yet
extremely important subject. Our pilot study
preliminarily addressed the role ofa combinato
rial natural product for the enhancement of male
sexual health. The proposed mechanism by
which ArginMax improves sexual health and
erectile function is through increasing smooth
muscle relaxation, enhancing vascular dilata
tion, and improving peripheral circulation. Based
on review of the literature pertaining to the
ingredients in ArginMax, it is likely that
ArginMax enhances the NO-cGMP pathway by
providing additional substrate forNOS, up regu
lating NOS activity, and decreasing the cell-
mediated breakdown of cGMP. On a vascular
level, ArginMax likely facilitates erectile func
tion by increasing blood vessel dilatation and
microvascular circulation.
It is important to recognize that this pilot
study is a part of a larger scale ongoing clinical
evaluation of the health effects of ArginMax.
Although designed as an open-label, pilot study,
the results of the SFQ survey demonstrate sig
nificantly greater improvements in variables
relating to erectile function than in non-erectile
function related variables. It is reasonable to
conclude that ifonly a placebo effect was noted,
all variables would be impacted in a similar
fashion. Thepresence ofmajor variations among
the variables leads us to believe that there is a
physiological effect at play. Our pilot study
indicates that an expansion of our current study
to a larger population with a placebo-controlled
protocol is the logical next step in exploring the
sexual function benefits of ArginMax.
It is important to recognize that as Americans
develop an ever increasing interest in dietary
supplementation and the concept of wellness,
that the role of a supplement for one of the most
important biological functions of life, sexual
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health, be clinically evaluated. After all, if we take a calcium
supplement for our bones, and an aspirin for our blood, why not
consider taking a supplement for our sexual health?
Conclusion
In a pilot clinical study of ArginMax (The Daily Weilness Com
pany, Mt. View, CA), a natural daily dietary supplement developed
to support male sexual fitness, significant improvements were noted
in male sexual function after 21 subjects, ages 40-77, with mild to
moderate erectile dysfunction, completed a 4 week regimen of
ArginMax. 88.9% of the subjects experienced improvement in
ability to maintain an erection during intercourse. 75.0% of the
subjects experienced improvement in satisfaction with their overall
sex life. There were no significant reports of side effects (headaches,
nausea, stomach upset, chest pain, dizziness, vision disturbance,
changes in BP). Based on the findings of this study, there appears to
be strong indication that natural dietary supplementation (ArginMax)
may play an important role in sexual health and erectile function.
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1 YEAR
• Excess risk of coronary heart
disease is half that of a
smoker
5 YEARS
• Lung cancer death rate for
average former smoker (one
pack a day) decreases by
almost half
• Stroke risk is reduced to that
of a nonsmoker 5-15 years
after quitting
• Risk of cancer of the mouth,
throat and esophagus is half
that of a smoker’s
10 YEARS
• Lung cancer death rate simi
lar to that of nonsmokers
• Precancerous cells are
replaced
• Risk of cancer of the mouth,
throat, esophagus, bladder,
kidney and pancreas
decreases
15 YEARS
•Risk of
coronary
heart
disease
isthat
of a non
smoker
20 MINUTES
• Blood pressure drops to
normal
• Pulse rate drops to normal
• Body temperature of hands
and feet increases to normal
8 HOURS
• Carbon monoxide level in
blood drops to normal
• Oxygen level in blood
increases to normal
24 HOURS
• Chance of heart attack
decreases
48 HOURS
• Nerve endings start
regrowing
• Ability to smell and taste
is enhanced
2 WEEKS te 3 MONTHS
• Circulation improves
• Walking becomes easier
• Lung function increases
up to 30 percent
1 to 9 MONTHS
• Coughing,
sinus con
gestion,
fatigue,
shortness of
breath decrease
• Cilia regrow in
lungs, increasing abil
ity to handle mucus, clean
the lungs, reduce infection
• Body’s overall energy
increases
Source: Ameucan Cancer Society;
Cenrers for Daease Conrrol and
Prevenrian
